Pharmafile Logo
Pharmafocus logo
Advanced Search

eczema

Showing 12 posts of 12 posts found.

UC San Diego School of Medicine researchers treat atopic dermatitis with bacteriotherapy

February 24, 2021
Research and Development atopic dermatitis, eczema

Researchers at the University of California San Diego School of Medicine have identified a universal strain of bacteria derived from …

News
dermatitis2015_-_copy

LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema

November 2, 2020
Research and Development, Sales and Marketing LEO Pharma, eczema, pharma

LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Virtual 2020 Virtual Congress …

News

FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema

March 25, 2020
Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment

Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …

News

Atopic dermatitis market set to almost triple in value over next 10 years

December 12, 2018
Research and Development atopic dermatitis, eczema, global data, markets, money

The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData. The market …

News

Novartis buys eczema drug in €95m deal

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, deal, eczema, experimental, patent

Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and …

News

NICE rejects Dupixent for atopic dermatitis on cost grounds, Sanofi responds

April 4, 2018
Research and Development, Sales and Marketing Dupixent, NICE, Sanofi, atopic dermatitis, eczema, pharma

UK drug watchdog NCIE has issued draft guidance rejecting the routine use of Sanofi’s Dupixent (dupilumab) for the treatment of …

News
novartis_window

Novartis acquires Ziarco adding to dermatology pipeline

December 19, 2016
Sales and Marketing Novartis, Ziarco, eczema, oral

Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …

News

Pfizer’s next blockbuster given FDA approval

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema

Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …

News
pfizer-building-logo1web

Pfizer announces strong Phase III results for atopic dermatitis drug

July 14, 2016
Research and Development Pfizer, anacor, atopic dermatitis, crisaborole, eczema

Pfizer (NYSE: PFE) has announced positive results from two pivotal Phase III studies for crisaborole in the treatment of mild …

News
eczema_finger

Featured Market Report: Atopic Dermatitis (eczema) Forecast in 17 Major Markets

December 7, 2015
Manufacturing and Production, Research and Development Black Swan, eczema

Featured Market Report: Forecast Report on Atopic Dermatitis (eczema) in 17 Major Markets  Black Swan’s report on Atopic Dermatitis, also …

Feature
Cream advert image

Genus reprimanded for ‘sexual and titillating’ advert

August 15, 2012
Sales and Marketing ABPI, Genus, PMCPA, breach, eczema

Genus has been found in breach of the ABPI Code after using a sexually charged image for the promotion of …

News
LinkedIn's recently launched Twitter integration

Digital Pharma: Byte-sized roundup

November 20, 2009
Medical Communications LinkedIn, digi, digital pharma, eczema, electronic patient records, patients

LinkedIn and Microsoft have signed a deal that will see the forthcoming version of Outlook incorporate feeds from the social networking platform.The …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023